Argenx
ARGX
#534
Rank
C$50.96 B
Marketcap
$816.15
Share price
-2.94%
Change (1 day)
59.33%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: C$50.96 Billion

As of April 2025 Argenx has a market cap of C$50.96 Billion. This makes Argenx the world's 534th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025C$50.96 B-5.16%
2024C$53.74 B79.55%
2023C$29.93 B5.25%
2022C$28.43 B21.34%
2021C$23.43 B31.09%
2020C$17.87 B99.01%
2019C$8.98 B88.1%
2018C$4.77 B89.48%
2017C$2.52 B
2014C$0.16 B

End of Day market cap according to different sources

On Apr 16th, 2025 the market cap of Argenx was reported to be:

C$49.77 Billion
by Nasdaq info icon info icon
C$49.83 Billion
by CompaniesMarketCap info icon info icon
C$49.83 Billion
by Yahoo Finance info icon info icon